Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis

Slides:

Advertisements

Similar presentations

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Advertisements

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Stephen R. Broderick, MD, MPHS

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD

Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer Takeshi Funatsu, MD, Yoshito.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients Joachim Pfannschmidt,

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience Tsuguo Naruke,

Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma Takahiro Mimae,

Tumors of the esophagogastric junction

Factors predictive of prognosis after esophagectomy for squamous cell cancer Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Mediastinal Nodal Involvement in Patients with Clinical Stage I Non–Small-Cell Lung Cancer: Possibility of Rational Lymph Node Dissection Tomohiro Haruki,

Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single- institution experience Bin Li, MD, Haiquan Chen, MD, Jiaqing Xiang,

The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao,

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy Morihito Okada, MD, Hiroyuki Yamagishi,

Boundary between N1 and N2 Lymph Node Descriptors in the Subcarinal Zone in Lower Lobe Lung Cancer: A Brief Report Mitsuhiro Isaka, MD, Haruhiko Kondo,

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung Cancer Jung-Jyh Hung, MD,

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic.

Prognostic factors in clinical stage I non–small cell lung cancer

Lorenzo Spaggiari, MD, PhD, Ugo Pastorino, MD

Proposed Revision Of The Staging Classification For Esophageal Cancer

Large cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighty- seven cases Hidefumi Takei, MDa,b, Hisao Asamura, MDb, Arafumi Maeshima,

A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions Hisao Asamura, MD, Kenji Suzuki,

Primary repair of rupture of a main and lobar bronchus

Support Your Specialty

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami.

Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 disease Steven M Keller, MD, Mark G Vangel, PhD, Henry Wagner,

Reasonable Extent of Lymph Node Dissection in Intentional Segmentectomy for Small- Sized Peripheral Non–Small-Cell Lung Cancer: From the Clinicopathological.

Is surgery for multiple lung metastases reasonable

Stephen R. Broderick, MD, MPHS

Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk.

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification Jacek Jassem, MDa, Jan.

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Multiple Primary Cancers or Multiple Metastases, That Is the Question

Yuji Tachimori, MD, Hoichi Kato, MD, Hiroshi Watanabe, MD

It’s All in the “Swerve of the Curve”

Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy Florian Loehe, MD, Sonja Kobinger, MD, Rudolf A Hatz, MD, Thomas.

“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin- section computed tomographic scan Kenji Suzuki, MD, Hisao Asamura,

Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,

Distribution and Likelihood of Lymph Node Metastasis Based on the Lobar Location of Nonsmall-Cell Lung Cancer Robert J. Cerfolio, MD, Ayesha S. Bryant,

Lymph Node Metastasis In Small Peripheral Adenocarcinoma Of The Lung

A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection Shiro Nagatani, MD, Yutaka Shimada,

Carcinoma of the esophagus: Prognostic significance of histologic type

Low-grade fibromyxoid sarcoma arising in the mediastinum

Problems related to TNM staging: Patients with stage III non–small cell lung cancer Kotaro Kameyama, MD, Cheng-long Huang, MD, Dage Liu, MD, Taku Okamoto,

Superior sulcus lung tumors: Impact of local control on survival

Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung Masami Sato, MDa, b, Teruaki Koike, MDa,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer Takayuki Fukui, MD, Shoichi Mori, MD, Kohei Yokoi, MD, Tetsuya.

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Left Pneumonectomy for Lung Cancer After Correction of Contralateral Partial Anomalous Pulmonary Venous Return Hiroyuki Sakurai, MD, Haruhiko Kondo,

Mark I. Block, MD The Annals of Thoracic Surgery

Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Marc Riquet, MD, PhD, Patrick Bagan,

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Presentation transcript:

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis Hisao Asamura, MD, Haruhiko Nakayama, MD, Haruhiko Kondo, MD, Ryosuke Tsuchiya, MD, Tsuguo Naruke, MD The Journal of Thoracic and Cardiovascular Surgery Volume 117, Issue 6, Pages 1102-1111 (June 1999) DOI: 10.1016/S0022-5223(99)70246-1 Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 1 Survival curve for all 166 patients with lung carcinoma with mediastinal lymph node metastasis. Five-year survival was 35%. Numbers in parentheses indicate number of patients still at risk at every postoperative year. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1102-1111DOI: (10.1016/S0022-5223(99)70246-1) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 2 Survival curves of patients with single-station metastases (MET) and multiple-station metastases. Five-year survivals for patients with single-station metastases and multiple-station metastases were 48% and 18%, respectively. Statistically significant difference between groups was observed (log rank test, P = .0006). Numbers in parentheses indicate number of patients still at risk at every postoperative year. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1102-1111DOI: (10.1016/S0022-5223(99)70246-1) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 3 Survival curves of patients with single-node metastases (MET) and multiple-node metastases. Five-year survivals for patients with single-node metastases and multiple-node metastases were 55% and 20%, respectively. Statistically significant difference between groups was observed (log rank test, P = .0002). Numbers in parentheses indicate number of patients still at risk at every postoperative year. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1102-1111DOI: (10.1016/S0022-5223(99)70246-1) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 4 Survival curves of patients with and without subcarinal node (station 7) metastases among 54 patients with right upper lobe (RUL) tumors. There was no statistically significant difference between groups (log rank test, P = .97). Numbers in parentheses indicate number of patients still at risk at every postoperative year. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1102-1111DOI: (10.1016/S0022-5223(99)70246-1) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 5 Survival curves of patients with and without superior mediastinal node metastasis (from station 1 through station 4) in 41 right lower lobe tumors. Five-year survival for patients with superior mediastinal metastasis was 4.1%. There was no statistically significant difference (log rank test, P = .55). Numbers in parentheses indicate the number of patients still at risk at every 1 year after surgery. The Journal of Thoracic and Cardiovascular Surgery 1999 117, 1102-1111DOI: (10.1016/S0022-5223(99)70246-1) Copyright © 1999 Mosby, Inc. Terms and Conditions